DiagnaMed Holdings Corp. (TSE:DMED) has released an update.
DiagnaMed Holdings Corp., a digital healthcare firm specializing in artificial intelligence, has announced its integration into the HEALTHI program to hasten the clinical research and commercial launch of its innovative CERVAI™ Brain Health AI Platform in Canada. The CERVAI™ technology, developed from research at Drexel University and the University of Miami, utilizes EEG data and a machine-learning model to estimate brain age and assess cognitive health, aiming to flag early stages of cognitive decline. The company is initiating a commercial test pilot program for CERVAI™ across various health clinics in the U.S. and Canada.
For further insights into TSE:DMED stock, check out TipRanks’ Stock Analysis page.
